| Npa Family Healthcare | |
|
1307 Bell Rd # 111 Antioch TN 37013-3745 | |
| (615) 953-3633 | |
| (615) 953-3635 |
| Full Name | Npa Family Healthcare |
|---|---|
| Speciality | Clinic/center - Primary Care |
| Location | 1307 Bell Rd, Antioch, Tennessee |
| Authorized Official Name and Position | John Madondo (NURSE PRACTITIONER) |
| Authorized Official Contact | 6155968099 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Npa Family Healthcare 1307 Bell Rd # 111 Antioch TN 37013-3745 Ph: (615) 953-3633 | Npa Family Healthcare 1307 Bell Rd # 111 Antioch TN 37013-3745 Ph: (615) 953-3633 |
| NPI Number | 1912292061 |
|---|---|
| Provider Enumeration Date | 06/16/2011 |
| Last Update Date | 12/08/2011 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912292061 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QP2300X | Clinic/center - Primary Care | (Tennessee) | Primary |
News Archive
Rahm Gummuluru, PhD, associate professor of microbiology at Boston University School of Medicine, and Bjoern Reinhard, PhD, professor of chemistry at Boston University, have been awarded a Research Project Grant from the National Institutes of Allergy and Infectious Diseases/National Institute of Health.
The inventors of a new and unique cancer immunotherapy developed at Roswell Park Comprehensive Cancer Center have announced a major step forward with that therapy, known as SurVaxM. MimiVax LLC principals Robert Fenstermaker, MD, and Michael Ciesielski, PhD, have announced that the company, spun off from Roswell Park in 2012, has entered into a China-exclusive licensing agreement for SurVaxM with Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd., a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical Co. Ltd. based in Shanghai, China.
Ligand Pharmaceuticals Incorporated today announced that its licensee, Onyx Pharmaceuticals, received accelerated approval from the U.S. Food and Drug Administration (FDA) for Kyprolis (carfilzomib) for Injection, a proteasome inhibitor indicated for the treatment of patients with multiple myeloma who have received at least two prior therapies, including bortezomib and an immunomodulatory agent, and have demonstrated disease progression on or within 60 days of completion of the last therapy.
Germany, New Zealand, Sweden and the United Kingdom on Thursday pledged $70 million to Zimbabwe to help the country address the growing number of children who have lost one or both parents to AIDS-related illnesses, Reuters South Africa reports.
› Verified 9 days ago
Hyde Park Medical Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5380 Hickory Hollow Pkwy, Antioch, TN 37013 Phone: 615-412-8662 | |
Anba Abraam Medical Clinic Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 555 Bell Rd, Antioch, TN 37013 Phone: 910-670-1718 Fax: 615-365-3443 | |
Patient Care Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 4200 Murfreesboro Pike, Antioch, TN 37013 Phone: 615-390-6775 Fax: 615-834-2053 |